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Abstract: While serological and virological evidence documents the exposure of bats to medically-
important arboviruses, their role as reservoirs or amplifying hosts is less well-characterized.
We describe a novel orbivirus (Reoviridae:Orbivirus) isolated from an Egyptian fruit bat (Rousettus
aegyptiacus leachii) trapped in 2013 in Uganda and named Bukakata orbivirus. This is the fifth
orbivirus isolated from a bat, however genetic information had previously only been available
for one bat-associated orbivirus. We performed whole-genome sequencing on Bukakata orbivirus
and three other bat-associated orbiviruses (Fomede, Ife, and Japanaut) to assess their phylogenetic
relationship within the genus Orbivirus and develop hypotheses regarding potential arthropod
vectors. Replication kinetics were assessed for Bukakata orbivirus in three different vertebrate cell
lines. Lastly, qRT-PCR and nested PCR were used to determine the prevalence of Bukakata orbivirus
RNA in archived samples from three populations of Egyptian fruit bats and one population of
cave-associated soft ticks in Uganda. Complete coding sequences were obtained for all ten segments
of Fomede, Ife, and Japanaut orbiviruses and for nine of the ten segments for Bukakata orbivirus.
Phylogenetic analysis placed Bukakata and Fomede in the tick-borne orbivirus clade and Ife and
Japanaut within the Culicoides/phlebotomine sandfly orbivirus clade. Further, Bukakata and Fomede
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appear to be serotypes of the Chobar Gorge virus species. Bukakata orbivirus replicated to high
titers (106–107 PFU/mL) in Vero, BHK-21 [C-13], and R06E (Egyptian fruit bat) cells. Preliminary
screening of archived bat and tick samples do not support Bukakata orbivirus presence in these
collections, however additional testing is warranted given the phylogenetic associations observed.
This study provided complete coding sequence for several bat-associated orbiviruses and in vitro
characterization of a bat-associated orbivirus. Our results indicate that bats may play an important
role in the epidemiology of viruses in the genus Orbivirus and further investigation is warranted into
vector-host associations and ongoing surveillance efforts.
Keywords: arbovirus; bat; orbivirus; next-generation sequencing; surveillance; Reoviridae
1. Introduction
Serological and virological evidence documents the exposure of various East African bat species
to several arboviruses including Rift Valley fever, dengue, and yellow fever virus [1,2], however, little is
known about the potential role of bats as arbovirus reservoirs or potential amplifying hosts. Orbiviruses
(Reoviridae:Orbivirus) are 10-segmented, dsRNA, vector-borne viruses that cluster phylogenetically by
arthropod vector group [3]. Recent research has also reported a novel orbivirus that may represent the
first recognized insect-specific virus in the genus Orbivirus [4]. While mostly recognized as veterinary
pathogens (i.e., bluetongue virus, African horse sickness), several orbiviruses have been associated
with neurologic disease in humans [5–8].
Prior to this study, four orbiviruses had been isolated from wild bats. Japanaut virus (JAPV)
was isolated from the blood of a southern blossom bat (Syconycteris crassa) and a pool of mixed
culicine mosquitoes in the Sepik District, New Guinea in 1965 [9,10]. Heramatsu orbivirus was
isolated from the blood of an eastern long-fingered bat (Myotis macrodactylus) trapped in a mine in
Heramatsu, Kagoshima, Japan in 1965 [11]. The genome of Heramatsu orbivirus (isolate KY-663) has
been partially sequenced [12]. Eight isolates of Ife virus (IFEV) were isolated from the blood and
organs of straw-colored fruit bats (Eidolon helvum) in Nigeria, Cameroon, and the Central African
Republic in 1971 and 1974 [13]. Gambian pouched rats (Cricetomys gambianus), African grass rats
(Arvicanthis niloticus), and domestic ruminants in Nigeria were also found to be seropositive for
IFEV [14–16]. Fomede virus (FOMV) was isolated from the brain, liver, and spleen of a dwarf slit-faced
bat (Nycteris nana) in Kindia, Guinea in 1978, and has been repeatedly isolated from Nycteridae bats in
Guinea [17–19]. Additionally, serologic evidence exists for exposure of Bolivian bats (genera Myotis
and Noctilio) to Matucare virus, an orbivirus isolated from Ornithodoros ticks in 1963 [20]. Australian
fruit bats were found to be seropositive to Elsey virus, a serotype of the mosquito-borne Peruvian
horse sickness virus [21].
In 2013, a novel orbivirus, tentatively named Bukakata orbivirus (BUKV), was isolated from an
Egyptian fruit bat (Rousettus aegyptiacus leachii (A. Smith, 1829)) (ERB) captured in Kasokero Cave,
Uganda (Figure 1). This is the fifth orbivirus isolated from bats; however, aside from partial sequencing
of Heramatsu, no bat-associated orbivirus has been genetically characterized. The specific aims of
this project were to 1) determine the genome sequence of the four bat-associated orbiviruses without
published existing genetic information (JAPV, IFEV, FOMV, & BUKV) and conduct phylogenetic
analyses to ascertain their potential arthropod associations, as orbiviruses cluster phylogenetically
based on their arthropod vector, 2) determine the replication kinetics of BUKV in multiple vertebrate
cell types, and 3) determine the prevalence of BUKV RNA in additional archived field samples
from Uganda.
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2. Materials and Method
2.1. Vi uses and ells
JAPV (MK 6357), IFEV (IbAn 57245), and FOMV (DakAnK 654) viruses were all sourced from the
Arbovirus Reference Collection at the Centers for Disease Control Arbovirus Diseases Branch in Fort
Collins, CO. BUKV (UGA432), isolated during this study, was deposited in the Arbovirus Reference
Collection following isolation on Vero cells (African green monkey kidney epithelial cells) (ATCC
CCL-81).
Vero cells and BHK-21 [C-13] cells (Syrian golden hamster kidney fibroblast) (ATCC CCL-10)
were maintained in Dulbecco’s minimal essential media supplemented with 5% fetal bovine serum
(FBS) (F0500-A, Atlas Biologicals, Fort Collins, CO, USA) and 1% penicillin/streptomycin (P/S)
(15140122, ThermoFisher Scientific, Rockford, IL, USA). R06E cells (BEI resources, NIAID, NIH: R06E,
R. aegyptiacus leachii (Egyptian fruit bat), Immortalized Fetal Cell Line, NR-49168) [22] were maintained
in DMEM-F12 (11330032, ThermoFisher Scientific, Rockford, IL, USA) with 5% FBS and 1% P/S. R06E
cells were tested and confirmed negative for contamination with Vero cells via DNAzol extraction and
Sanger sequencing using Barcode of Life CO1 primers [23,24]. All cell lines were tested for presence of
Mycoplasma spp. using PCR and were found to be negative using the ATCC Universal Mycoplasma
Detection Kit (Cat. no. 30-1012K) (ATCC, Manassas, VA, USA).
2.2. Bat Capture and Sampling
Bats were captured from multiple locations throughout Uganda during 2011–2013 [2]. Seventy-one
additional combined liver and spleen tissue RNA samples from ERBs captured previously at
Maramagambo Forest in 2009 were provided for inclusion in this study (Table 1, Figure 1). All bat
captures were conducted under the approval of IACUC protocols 1731AMMULX (samples from
Maramagambo Forest) and 010-015 (all other samples). Bats were captured using harp traps or
mist nets. Sampling locations, numbers and species captured, and blood collection and serological
results from these samples are described elsewhere [2,25]. All bats were euthanized according to
approved IACUC protocols in accordance with AVMA guidelines to harvest tissues for virus isolations.
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Tissues collected included lung, intestine, liver, spleen, and oral and fecal swabs. Tissue sections were
immediately placed in cryotubes and liquid nitrogen dry shippers. Duplicate aliquots of serum and
liver/spleen were analyzed first for filovirus RNA at the CDC Viral Special Pathogens laboratory in
Atlanta, GA USA.
Table 1. Sampling locations and dates for Egyptian fruit bats (R. aegyptiacus leachii) screened for BUKV
RNA [2].
Location Latitude Longitude n Tissue Type Date Collected
Python Cave,
Maramagambo Forest −0.26667 30.05000 71 Liver and spleen Nov 09
Kasokero cave −0.34214 31.96627 56 Spleen Jan 13
Tutum cave 1.28333 34.46667 45 Spleen Feb 12
Filovirus-negative liver and spleen specimens were homogenized for virus isolation.
Approximately 0.5 cm3 sections of tissue were mechanically homogenized in a 2.0 mL snap cap
tube containing 1 mL BA1 medium (Hanks M-199 salts, 0.05 M Tris pH 7.6, 1% bovine serum albumin,
0.35 g/L sodium bicarbonate, 100 U/mL streptomycin, 1 µg/mL Fungizone) and one or two stainless
steel 5 mm beads in a Qiagen mixer mill (Qiagen, Valencia, CA, USA) at 25 cycles/sec for four minutes.
Homogenates were clarified by centrifugation at approximately 12,800× g for 8 min at 4 ◦C and stored
at −80 ◦C. A 100 µL aliquot of supernatant was inoculated directly onto Vero cell monolayers, with
one sample per well on a 6-well plate for virus isolation by double-overlay plaque assay [26]. A second
overlay containing neutral red was added four days post infection, and plates were observed for
plaques up to 10 days post infection. Cells from plaque-positive wells were harvested into 1 mL
DMEM + 10% fetal bovine serum and clarified by centrifugation and the infected supernatant was
stored at −80 ◦C. The viral RNA from plaque-positive samples was extracted from 200 µL of the
supernatant and eluted into a final volume of 140 µL AE buffer using the Qiagen BioRobot EZ1
Workstation using the EZ1 Virus Mini Kit v2.0. From the infected bat, additional sections of liver, lung,
intestine, and oral and fecal swabs were also processed for virus isolation as above.
2.3. Sequencing and Bioinformatics Analysis
Initial sequencing of the novel virus isolate and bioinformatics analysis was performed following
published methods [27]. RNA was extracted from FOMV, IFEV, and JAPV virus isolates using the
MagMAX Viral RNA Isolation Kit (Life Technologies, Carlsbad, CA, USA) and DNAse treated using
the TURBO DNA-free™ kit (Ambion, Austin, TX, USA). Library preparation was carried out using
ScriptSeq™ v2 RNA-Seq Library Preparation Kit (Epicentre Biotechnologies, Madison, WI, USA)
and ScriptSeq™ Index PCR Primers (Epicentre Biotechnologies, Madison, WI, USA). Libraries were
pooled and sequenced on the Illumina MiSeq using the MiSeq Reagent Kit v2 (300 cycles) (Illumina,
San Diego, CA, USA). RNA was Trizol extracted from Vero cell supernatant for the novel orbivirus
isolate, BUKV (UGA432), and the library was prepared using the Kapa RNA HyperPrep kit (Kapa
Biosystems, Wilmington, MA, USA). The library was sequenced on the Illumina MiSeq using the
MiSeq Reagent Micro Kit v2 (300 cycles) (Illumina, San Diego, CA, USA).
Low-quality bases and barcoded sequencing adapters were removed using Cutadapt, duplicate
reads were collapsed using cd-hit, and host reads were filtered using Bowtie2 [28–30]. De novo
assembly was performed using SPADES assembler and contigs were searched for homology against
the NCBI Viral RefSeq database at the nucleotide (blastn) and amino acid (blastx) levels [31]. Contigs
representing orbivirus genomic segments were validated by remapping the quality- and host-filtered
reads using Bowtie2 [28]. The resulting alignments were visually inspected to confirm that mapping
depth and base-calls were sufficient for accurately determining the sequence of each open reading frame
for each genomic segment. Putative open reading frames were characterized using open reading frame
(ORF) prediction (Geneious v11.1.15, Biomatters, Auckland, New Zealand) and comparing the output
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(ORF start/stop/length etc.) to related orbiviruses. This workflow resulted in a coding-complete
consensus sequences for all ten segments of JAPV, FOMV, and IFEV, and for nine of ten segments
for BUKV.
2.4. Phylogenetic Analysis
Genome regions of interest included the highly conserved RNA-dependent RNA polymerase
(VP1), sub-core shell protein (T2 (VP2/VP3)), and the major-core surface protein (T13 (VP7)) [32,33].
Multiple alignment and phylogenetic analysis were analyzed for these three genes using the newly-
derived consensus sequences obtained for the four bat-borne orbiviruses in addition to previously
genetically characterized orbivirus sequences obtained from GenBank (AHSV = African horse sickness,
BTV = Bluetongue virus, CGLV = Changuinola virus, CGV = Chobar Gorge virus, CORV = Corriparta
virus, EEV = Equine encephalosis virus, EHDV = Epizootic hemorrhagic disease virus, EUBV =
Eubenangee virus, FENGV = Fengkai virus, GIV = Great Island virus, KEMV = Kemerovo virus, LEBV
= Lebombo virus, LIPV = Lipovnik virus, ORUV = Orungo virus, PALV = Palyam virus, PATAV =
Pata virus, PHSV = Peruvian horse sickness virus, SVIV = Sathuvachari virus, SCRV = St. Croix River
virus, SLOV = Stretch Lagoon orbivirus, TIBV = Tibet orbivirus, TILV = Tilligerry virus, TRBV = Tribec
virus, UMAV = Umatilla virus, WMV = Wad Medani virus, WALV = Wallal virus, WARV = Warrego
virus, YUOV = Yunnan virus) (Table S1). Putative open reading frames were translated and aligned in
SeaView version 4 [34] using Clustal Omega [35], and then back-translated to nucleotide sequence.
Nucleotide alignments were trimmed using TrimAl in order to remove poorly aligned regions [36].
The best-fit substitution models for nucleotide alignment and protein alignment were determined
using jModelTest 2.1.10 [37,38] and ProtTest 3.4.2 [38,39], respectively. Best-fit substitution models
were selected based on lowest BIC and AIC scores. The best-fit substitution models selected for
amino acid multiple alignment as determined by ProtTest was LG with gamma distribution including
estimation of invariant sites (LG + G + I) for VP1, T2, and T13. The best-fit substitution models selected
for nucleotide multiple alignment as determined by jModelTest were generalized-time reversible
with gamma distribution including estimation of variant sites (GTR + G + I) for VP1 and T2, and
generalized-time reversible with gamma distribution (GTR + G) for T13. Nucleotide trees were
prepared using the Bayesian Markov Chain Monte Carlo method, as implemented in MrBayes 3.2.5 [40].
The analysis was performed for five million steps, with sampling every 1000 steps and discarding
the first 10% as burn-in. Amino acid maximum-likelihood trees were prepared in MEGA7 with 1000
bootstrap replicates [41,42].
2.5. Multi-Step Growth Curves
Confluent T-12.5 flasks of Vero cells, BHK-21 [C-13] cells, and R06E cells were inoculated with
BUKV in triplicate at a MOI of 0.01. Triplicate mock-infected flasks served as negative controls.
An additional flask for each cell line was prepared to count cells and ensure an accurate MOI calculation.
Cells were allowed to incubate with virus for 60 min at 37 ◦C, and then washed with 1× phosphate
buffered saline (PBS) three times prior to replacing maintenance media (DMEM with 2% FBS and
1% P/S for Vero cells and BHK-21 [C-13] cells, DMEM-F12 with 2% FBS and 1% P/S for R06E cells).
Immediately, 100 µL was taken for the 0 h post-infection timepoint and proportion FBS was increased
to 20% prior to freezing at −80 ◦C. Additional time points were collected at 12, 24, 48, 72, and 96 h
post-infection. Back-titrations were performed in duplicate to confirm each inoculum was within
two-fold of the desired titer. Viral quantification was assessed by plaque titration as previously
described using Vero cell plaque assay [43].
2.6. Screening of Archived Field Samples for BUKV
In total, RNA extractions from 171 ERBs representing three populations in Uganda were available
for screening [2] (Table 1, Figure 1).
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RNA was extracted using the MagMax 96 total RNA isolation kit (Applied Biosystems/Ambion,
Austin, TX, USA). Eluted RNA from splenic samples was tested in a quantitative reverse-transcriptase
PCR (qRT-PCR) assay using TaqMan Fast Virus 1-Step Master Mix (ThermoFisher Scientific,
Foster City, CA, USA). Each sample was run in duplicate using primers and probe (5′-3′) (F′:
GCAGACTGTATCGCGGAAAG, R′: TAAGTTTCGCTTTCCTCCCGA, probe: CTGAAACTCGATC
TCCGCAACGTTCTT) targeting the VP1 gene (RdRp) of BUKV and as single reactions using
primers and probe targeting the GAPDH gene (F′: GTCGCCATCAATGACCCCTTC, R′: TTCAA
GTGAGCCCCAGCC, probe: CCACCCATGGCAAGTTCAAAGGCACA) to ensure RNA integrity.
Each reaction contained 5 µL splenic RNA, 5 µL TaqMan Fast Virus 1-Step Master Mix, 500 nM each
primer, 250 nM probe, and 7.5 µL H2O. All samples were run on a QuantStudio 3 thermocycler using
the following cycling parameters: 50 ◦C for 5 min; 95 ◦C for 20 s; 95 ◦C for 3 s, 60 ◦C for 30 s (40×).
As a positive control, supernatant from BUKV-infected Vero cells was 10-fold serially diluted and
from each dilution, RNA was extracted using the Mag-Bind Viral DNA/RNA 96 kit (Omega Bio-Tek,
Norcross, GA, USA) on the Kingfisher® extraction system (Thermo Scientific, Rockford, IL, USA).
Additionally, plaque assays of the dilution series were performed in duplicate on Vero cells to quantify
viral titer [43]. A linear regression was performed to correlate viral titer to cutoff threshold value
determined by QuantStudio™ Design & Analysis Software run on the QuantStudio™ 3 polymerase
chain reaction system (Thermo Scientific, Rockford, IL, USA). The same parameters were used to
screen the tick samples. Archived RNA extracted from pooled Ornithodoros faini soft ticks collected
in Python Cave, Maramagambo forest, Uganda, were screened for BUKV RNA following the same
protocol as for archived bat sample testing [44].
Samples with questionable or suspect-positive results (cycle threshold value of 35–40 or nearing
the cycle threshold cutoff) using qRT-PCR were subjected to a nested PCR protocol using the Phusion
HiFi Master Mix (New England BioLabs, Beverly, MA, USA) and run on a T100™ Thermal Cycler
(Bio-Rad, Hercules, CA, USA). As a positive control, a synthetic oligonucleotide control was generated
targeting a 406 bp region of VP1 to facilitate recognition of a false positive result by Sanger sequencing
(Integrated DNA Technologies, Inc., Coralville, IA, USA) (Table S2). Cycling parameters for both
Round 1 (F′: 5′-CGCTCCGTCATTGGTTTGCA-3′, R′: 5′-ATAGCTTCGCTTACGCCGGT-3′) and Round
2 (F′: 5′-TCCTTGTCTCAATCGCGCGT-3′, R′: 5′-AGCGACAAAGCCTCCACAGA-3′) were as follows:
98 ◦C for 30 s; 98 ◦C for 7 s, 68.5 ◦C for 15 s, 72 ◦C for 20 s (30×); and 72 ◦C for 6 min.
3. Results
3.1. Virus Isolation
Four days post-inoculation on Vero cells, plaques were visible for the spleen of bat #432 (UGA432,
JCK8050, FMNH 223820) (Figure S1), a young male ERB captured in Kasokero cave in January 2013
(Table 1, Figure 1). Of the additional tissues harvested from the infected bat and tested for BUKV, only
liver and spleen were positive for infectious virus by plaque assay; lung, oral and fecal swabs, and
intestine were negative.
3.2. Genome Sequencing
Complete coding sequences were obtained for all ten segments of FOMV, IFEV, and JAPV, and
for all segments besides segment 3 of BUKV. Each segment possessed one gene encoding one protein,
with the exception of segments 9 and 10, which each contained a second shorter ORF similar to other
orbiviruses [45,46]. The size and GC% content for each ORF, in addition to its closest match to available
data on GenBank using BLASTX (predicted translation product from six reading frames) and its
GenBank accession number are listed in Tables 2–5.
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Table 2. Genetic analysis of BUKV genome segments, predicted ORFs, and predicted proteins.
Seg. ProteinEncoded
ORF
Length
(nt)
Pred. Protein
Length
%GC
Content
(ORF)
Top Blastx (ORF)
[Nearest Virus 1],
Accession, %
Pairwise Identity
Accession #
1 VP1 3855 1285 51.9 VP1 (Pol) [CGV],YP_009158901, 83.6% MK359215
2 VP2 (T2) 2730 2730 52.3 VP2 (T2) [CGV],YP_009158902, 91.7% MK359216
3 VP3 (Cap) N/A 2 N/A 2 N/A 2
VP3 (Cap) [CGV],
YP)009158903, 74.5% MK359217
4 VP4 (OC1) 1761 587 50.9 VP4 (OC1) [CGV],YP_009158904, 60.1% MK359218
5 NS1 (TuP) 1575 525 55.3 NS1 (TuP) [CGV],YP_009158905, 80.2% MK359219
6 VP5 (OC2) 1608 536 53.7 VP5 (OC2) [CGV],YP_009158906, 79.8% MK359220
7 VP7 (T13) 1068 356 54.1 VP7 (T13) [CGV],YP_009158907, 88.2% MK359222
8 NS2 (ViP) 1110 370 54.6 NS2 (ViP) [CGV],YP_009158908, 76.7% MK359221
9
VP6 (Hel) 1041 347 53.2 VP6 (Hel) [CGV],YP_009158909, 54.3%
MK359223
NS4 717 239 54.4 VP6 (Hel) [CGV],YP_009158909, 54.3%
10
NS3 621 207 52.3 NS3 [CGV],YP_009158911, 90.3%
MK359224
NS3a 579 193 52.0 NS3a [CGV],YP_009158912, 90.1%
1 CGV = Chobar Gorge virus. 2 Partial ORF provided as sequencing coverage at 5′ end was too low to obtain
start codon.
Table 3. Genetic analysis of FOMV genome segments, predicted ORFs, and predicted proteins.
Seg. ProteinEncoded
ORF
Length
(nt)
Pred. Protein
Length
%GC
Content
(ORF)
Top Blastx (ORF)
[Nearest Virus 1],
Accession, %
Pairwise Identity
Accession #
1 VP1 3855 1285 52.7 VP1 (Pol) [CGV],YP_009158901, 82.8% MK359225
2 VP2 (T2) 2730 910 50.9 VP2 (T2) [CGV],YP_009158902, 90.9% MK359226
3 VP3 (Cap) 1908 636 53.7 VP3 (Cap) [CGV],YP_009158903, 71.4% MK359227
4 VP4 (OC1) 1761 587 50.3 VP4 (OC1) [CGV],YP_009158904, 69.3% MK359228
5 NS1 (TuP) 1575 525 55.7 NS1 (TuP) [CGV],YP_009158905, 78.6% MK359229
6 VP5 (OC2) 1608 536 54.7 VP5 (OC2) [CGV],YP_009158906, 83.2% MK359230
7 VP7 (T13) 1068 356 53.2 VP7 (T13) [CGV],YP_009158907, 89.0% MK359232
8 NS2 (ViP) 1110 370 56.0 NS2 (ViP) [CGV],YP_009158908, 77.2% MK359231
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Table 3. Cont.
Seg. ProteinEncoded
ORF
Length
(nt)
Pred. Protein
Length
%GC
Content
(ORF)
Top Blastx (ORF)
[Nearest Virus 1],
Accession, %
Pairwise Identity
Accession #
9
VP6 (Hel) 1041 347 55.1 N/A 2
MK359233
NS4 717 239 55.2 NS4 [CGV],YP_009158910, 60.2%
10
NS3 621 207 53.9 NS3 [CGV],YP_009158911, 88.8%
MK359234
NS3a 570 190 53.5 NS3a [CGV],YP_009158912, 89.4%
1 CGV = Chobar Gorge virus. 2 No blastx matches.
Table 4. Genetic analysis of JAPV genome segments, predicted ORFs, and predicted proteins.
Seg. ProteinEncoded
ORF
Length
(nt)
Pred. Protein
Length
%GC
Content
(ORF)
Top Blastx (ORF)
[Nearest Virus 1],
Accession, %
Pairwise Identity
Accession #
1 VP1 3900 1300 38.3 VP1 [TIBOV],APT68074, 66.3% MK359235
2 VP2 (OC1) 3636 1212 39.2 VP2 (OC1) [BTV-2],CAO79540, 22.1% MK359236
3 VP3 (T2) 2703 901 40.9 VP3 (T2) [PATV],AFH41521, 72.0% MK359237
4 VP4 (Cap) 1932 644 40.7 VP4 (Cap) [BTV-12],ASV51737, 57.6% MK359238
5 NS1 (TuP) 1662 554 44.8 NS1 (TuP) [EHDV-7],AIY25176, 30.3% MK359239
6 VP5 (OC2) 1590 530 43.1 VP5 (OC2) [CGLV],AGZ91948, 54.0% MK359240
7 VP7 (T13) 1053 351 44.5 VP7 (T13) [CGLV],YP_008719923, 57.1% MK359241
8 NS2 (ViP) 1011 337 43.8 NS2 (ViP) [CGLV],AGZ91980, 42.6% MK359242
9
VP6 (Hel) 804 268 44.7 VP6 (Hel) [WALV],YP_008658421, 32.7% MK359243
NS4 234 78 48.7 N/A 2
10
NS3 786 262 43.6 NS3 [TILV],AFH41508, 39.1% MK359244
NS3a 642 214 44.5 NS3 [TILV],AFH41508, 39.1%
1 BTV = Bluetongue virus, CGLV = Changuinola virus, EHDV = Epizootic hemorrhagic disease virus, PATV = Pata
virus, TIBOV = Tibet virus, TILV = Tilligerry virus, WALV = Wallal virus. 2 No blastx matches.
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Table 5. Genetic analysis of IFEV genome segments, predicted ORFs, and predicted proteins.
Seg. ProteinEncoded
ORF
Length
(nt)
Pred. Protein
Length
%GC
(ORF)
Top Blastx (ORF)
[Nearest Virus 1],
Accession, %
Pairwise Identity
Accession #
1 VP1 3900 1300 39.7 VP1 [Heramatsu],AGZ62525, 62.0% MK359245
2 VP3 (T2) 2685 895 42.6 VP3 (T2) [Heramatsu],AGZ62528, 61.9% MK359246
3 VP2 (OC1) 2523 841 41.7
VP2 (OC1)
[Heramatsu],
AGZ62527, 29.1%
MK359247
4 VP4 (Cap) 1902 634 42.0
VP4 (Cap) partial
[Heramatsu],
AGZ62529, 52.7%
MK359248
5 NS1 (TuP) 1581 527 44.7 NS1 (TuP) [LEBV],YP_009507714, 32.0% MK359249
6 VP5 (OC2) 1569 523 43.0 VP5 (OC2) [CGLV],AGZ91955, 46.8% MK359250
7 VP7 (T13) 1047 349 46.2 VP7 (T13) [WALV],YP_008658420, 41.7% MK359251
8 NS2 (ViP) 990 330 44.1
NS2 (ViP)
[Heramatsu],
AGZ62533, 40.5%
MK359252
9
VP6 (Hel) 768 256 47.5
VP6 (Hel) partial
[Heramatsu],
AGZ62534, 34.7% MK359253
NS4 240 80 53.8 N/A 2
10
NS3 612 204 46.6 NS3 [Heramatsu],AGZ62526, 47.1% MK359254
NS3a 561 187 46.3 NS3 [Heramatsu],AGZ62526, 47.1%
1 CGLV = Changuinola virus, LEBV = Lebombo virus, WALV = Wallal virus. 2 No blastx matches.
3.3. Phylogenetic Analysis
Amino-acid maximum-likelihood trees constructed in MEGA7 for VP1, T2, and T13 are provided
(Figures 2–4), as are nucleotide phylogenetic trees estimated using the MCMC method in MrBayes
(Supplemental Figures S2–S4). Phylogenetic tree topology consistently places BUKV and FOMV viruses
with the tick-borne orbiviruses and JAPV and IFEV with the Culicoides/sandfly-borne orbiviruses.
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3.4. Growth Curves
Propagation of BUKV was successful in all three mammalian cell lines tested (Vero, BHK-21 [C-13],
and R06E cells) with viral titers peaking at 24 hpi in all three cell lines, and the highest titer achieved
in BHK-21 [C-13] cells (1.6 × 107 PFU/mL at 24 hpi) (Figure 6). Cytopathic effect was detected in all
three cell lines between 12 and 24 hpi.
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Figure 6. Comparison of growth kinetics of BUKV in Vero, BHK-21 [C-13], and R06E cells when infected
at MOI 0.01. Means and SEs from three independent replicates are shown. Statistics were performed
using a two-way ANOVA with Tukey’s correction at each time point. p-values: 12 hpi: <0.0001 (Vero
vs. BHK-21 [C-13]), 0.0328 (Vero vs. R06E), <0.0001 (BHK-21 [C-13] vs. R06E; 24 hpi: <0.0001 (Vero
vs. BHK-21 [C-13]), <0.0001 (BHK-21 [C-13] vs. R06E; 48hpi: <0.0001 (Vero vs. BHK-21 [C-13]), 0.0009
(Vero vs. R06E), <0.0001 (BHK-21 [C-13] vs. R06E). Asterisks in figure indicate the number of two-way
comparisons that were significant (p < 0.05) at each timepoint.
3.5. Testing of Additional Bat and Tick Samples
None of the 171 bat samples screened via qRT-PCR resulted in amplification of BUKV VP1 RNA,
though six were suspected or weak positive. None of the six suspect-positive bat samples were
confirmed positive for BUKV RNA by nested PCR. Of the 171 samples, GAPDH RNA was successfully
amplified from 86% (147/171) confirming RNA integrity. Of the 513 tick pools tested, 16s rRNA
internal extraction control was amplified from 485, and none were positive for BUKV VP1 RNA.
4. Discu sion
Bats are known to host a number of emerging zoonotic viruses highly pathogenic to humans in
the absence of overt pathology within the bat host. Limited information exists, however, about the
ability of bat species to harbor and transmit medically important arboviruses. Despite extensive
serologic evidence suggestive of exposure of multiple bat species to arboviruses from different
families (Flaviviridae, Togaviridae, and Bunyavirales), few studies have resulted in the isolation
of arboviruses from wild-caught bats. Molecular and in vivo characterization of novel viruses isolated
from wild-caught bats, in addition to enhanced surveillance efforts targeting suspected hosts helps
clarify the role of bats as reservoirs for emerging arboviruses.
This study provides co pl te coding sequences f three previo ly uncharacterized rbiviruses
isolated from bats (JAPV, IFEV, and FOMV) and one novel bat-associated orbivirus, BUKV, isolated
from an ERB. Phylogenetic analyses place BUKV and FOMV in the tick-borne orbivirus clade, and
IFEV and JAPV cluster with the Culicoides/sandfly-borne orbiviruses. This study also provides
documentation for in vitro propagation of a bat-associated or iviru in a number of different vertebrate
cell lines, one of which was derived from the ERB. The screening of additional archived bat and tick
samples resulted in negative findings, but reflects a critical step in the investigation process into the
host-vector relationships supported by phylogenetic analyses.
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Of the three segments analyzed, the topology of the phylogenetic analysis consistently placed
BUKV and FOMV within the tick-borne orbivirus subclade along with Chobar Gorge virus (CGV).
Past studies indicated that FOMV is a serotype of the Chobar Gorge virus species based on results of
complement fixation, and it is considered as such by the International Committee on the Taxonomy
of Viruses [3,47,48]. This is consistent with past isolations of FOMV in field-caught Ixodid ticks [17].
CGV has been isolated from Ornithidoros spp. ticks in Nepal, and antibodies have been detected in
humans and domestic ruminant species in the same region [49]. Additionally, the clustering of BUKV,
FOMV, and CGV within the same subclade of tick-borne orbiviruses and high degree of nucleotide and
amino acid similarity regardless of protein analyzed suggests they are three different serotypes of the
same species Attoui et al. suggested that the amino acid identity for T2 of <91% should be the criteria
for designating a species within the genus Orbivirus [50]. According to that criterion BUKV and
FOMV viruses are on the border for consideration as new species. BUKV possesses 95.27% amino acid
similarity to FOMV and 91.56% similarity to CGV, and Fomede possesses 90.87% amino acid similarity
to CGV. Bukakata and Fomede viruses may be ecologically unique from Chobar Gorge in having
been isolated from bats, however it is not known whether or not Chobar Gorge virus is also found in
bats. Further characterization into the evolutionary relationship of these bat-associated and potentially
tick-borne orbiviruses should involve exploration into in vitro growth kinetics in invertebrate cell lines
in addition to the potential for serologic cross-reactivity and in vitro reassortment potential.
JAPV and IFEV cluster with the Culicoides/sandfly-borne orbivirus clade and have not yet been
approved as species of orbiviruses, but novel genetic sequence obtained during this study indicates
that their listing should be revised. Neither JAPV nor IFEV possess the requisite >76% nucleotide
identity to any other orbivirus in their conserved T2 gene, indicating they are each their own individual
species [3] (Figure 5). In the analysis of all three segments, IFEV is very distantly related to all other
orbiviruses and may represent its own species due to the low level of nucleotide (maximum 55.7%)
and amino acid similarity (maximum 59.3%) to any other orbivirus when analyzing the gene encoding
sub-core shell T2 protein (Figure 5). Interestingly, the BLASTX results for IFEV virus segments reveal
that it is most closely related to Heramatsu orbivirus. Heramatsu virus was obtained from a Japanese
eastern long-fingered bat in 1965 and was partially sequenced in 2013 [11,12]. However, due to lack
of complete genome information and access to an archive isolate, this virus was not included in our
phylogenetic analyses.
Due to their segmented genome, orbiviruses are known to undergo reassortment during
co-infection [51,52]. Comparing the placement of JAPV within the VP1 and T2 phylogenies to its
placement in the T13 phylogeny suggests that it may have undergone reassortment; however, definitive
conclusions surrounding its potential as a reassortant virus are difficult to make due to low bootstrap
values and posterior probabilities (Figures 2–4, Figures S2–S4). Interestingly, our phylogenetic analyses
indicate JAPV clusters with the Culicoides/sandfly-borne orbiviruses, though it was isolated from a
pool of Culicine mosquitoes in New Guinea [10]. Further investigation is required to better characterize
potential vector-host associations for JAPV and its potential as a reassortant orbivirus.
BUKV grew to high titers in all three vertebrate cell lines in which multi-step growth curves were
conducted. Two of these cell lines, Vero cells and BHK-21 [C-13] cells, are deficient for the interferon
pathway, while the R06E pathway has an intact interferon response [53]. The Type I interferon
response is the first line of antiviral defense in the mammalian immune system [54]. Interestingly,
viral titers in interferon-competent R06E cells were comparable to interferon-deficient BHK-21 [C13]
and Vero cells (Figure 6). The immune system of some bat species is highly unique in its constitutive
expression of IFN-α [55]. A recent study by Pavlovich and colleagues indicate that unlike Pteropus alecto,
transcriptomic analysis of the ERB does not provide evidence of constitutive interferon expression [56].
Analysis of interferon expression over the course of infection in bat cells and other interferon-competent
vertebrate lines would be an informative way to analyze the presence of this constitutive expression in
existing bat cell lines.
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None of the 171 bat samples or 513 tick pools tested positive for BUKV viral nucleic acid. However,
GAPDH mRNA was tested for each bat sample and samples for which amplification of the GAPDH
was not obtained were not included in the denominator of the total tested samples. While all samples
were negative for BUKV RNA, some of the bat samples had very high CT values or were nearing the
cycle threshold and as such, were considered to be suspect and subjected to a nested PCR protocol. The
six suspect samples tested using this nested PCR were also confirmed negative. Samples types screened
(spleen and/or liver) are consistent with the organs from which the virus was originally isolated.
Testing additional bat species for viral RNA could yield additional information on the circulation of
this virus.
While this study provides valuable information regarding potential vector-host associations
among the orbiviruses, limitations restrict certain conclusions. Each orbivirus segment contains 1–2
genes, with untranslated regions on either end of the ORF. Due to decreased coverage at the ends of the
reads, variable coverage was achieved throughout the length of each segment and only the complete
coding genome of IFEV, JAPV, and FOMV were obtained. The coding complete sequence of segments
1–2 and 4–10 were obtained for BUKV but due to low coverage at the 5′ end of segment 3, the start
codon was not obtained (Table 2). Individual orbivirus species possess conserved 5′ UTR and 3′ UTR
terminal sequences and as such, higher coverage in the untranslated regions would have provided
additional information surrounding level of relatedness between these and previously sequenced
orbiviruses [3]. Field surveillance efforts were opportunistic and retrospective, and only ERB RNA was
tested. The testing of additional bat species from nearby geographic areas sharing similar ecological
habitats would provide additional information surrounding vertebrate host range. The tick pools
tested were also opportunistic and retrospective, and originated in Python Cave, a cave with analogous
ecological characteristics to Kasokero Cave, where BUKV was isolated, yet 213 km away (Table 1,
Figure 1).
5. Conclusions
This study provided coding of the complete genome sequence on three bat-associated orbiviruses
that have been discovered to date, and coding the complete sequence for nine of ten segments for a
newly isolated bat-associated orbivirus. Further, in vitro replication kinetics were described in three
vertebrate cell lines. From the phylogenetic analyses, inference regarding potential arthropod vector
associations can be drawn regarding transmission of bat-associated orbiviruses and supports ticks
as a potential vector of BUKV. While the archived bat and tick samples tested for BUKV RNA were
negative, this study provides a strong framework for comprehensive viral characterization, including
initial discovery, in vitro characterization, and the screening of samples collected from the potential
vertebrate host and the purported invertebrate vector. The isolation of five orbiviruses from distinct
bat species located across space and time and phylogenetically-associated with different arthropod
vectors indicates a strong association between orbiviruses and bats, and further investigation into the
public health impact of these orbiviruses is warranted.
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